SHCM
EXAS

Sachem Head Capital Management’s Exact Sciences EXAS Stock Holding History

Sachem Head Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-425,000
Closed -$24.6M – 20
2020
Q1 		$24.6M Buy
+425,000
New +$34.5M 2.4% 11

Other funds holding EXAS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Sachem Head Capital Management's EXAS Position: Q2 2020 in Review

Sachem Head Capital Management sold out of Exact Sciences (EXAS) in Q2 2020, closing a stake of 425,000 shares — an estimated $24.6M sold.

Sachem Head Capital Management first reported a position in EXAS in Q1 2020 and held it in 1 quarter. The position peaked at $24.6M in Q1 2020. 513 funds tracked by Wall St. Rank hold EXAS as of Q2 2020.

  • Sachem Head Capital Management reported no remaining Exact Sciences position as of Q2 2020 after selling out during the quarter.
  • Sachem Head Capital Management sold 425,000 Exact Sciences shares in Q2 2020, an estimated $24.6M.
  • Sachem Head Capital Management first reported a position in Exact Sciences in Q1 2020 and held it in 1 quarter.
  • Sachem Head Capital Management's Exact Sciences position peaked at $24.6M in Q1 2020.
  • 513 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2020.

Based on Sachem Head Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.